Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-006930
Filing Date
2024-09-10
Accepted
2024-09-10 16:21:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3329
  Complete submission text file 0001950047-24-006930.txt   4809
Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Vignola Mark J. (Reporting) CIK: 0001775429 (see all company filings)

Type: 144

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Subject) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39926 | Film No.: 241290333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)